http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106188229-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1016 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-103 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-107 |
| filingDate | 2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106188229-B |
| titleOfInvention | It is a kind of using free glycine and L-cysteine as the synthetic peptide of pharmacological activity group |
| abstract | The invention belongs to biomedicine technical fields, and in particular to a kind of synthetic peptide and its purposes in preparation treatment cerebral injury drug.The amino acid sequence of the synthetic peptide is X1- (Gly-L-Cys) n-L-Ala-X2-X3(I), in formula, X1 be without or L-Phe, X2 be without L-Cys, X3 be without or L-Phe, X1, X3 cannot simultaneously be nothing, n≤8.Animal experiments show that such synthetic peptide can pass through intravenous administration approach under extremely low dosage; through blood-brain barrier; reach brain; hydrolysis generates free glycine and cysteine and plays neuroprotection under the action of intracerebral proteolytic enzyme; the ischemic perfusion injury for reducing brain plays the purpose for the treatment of cerebral apoplexy. |
| priorityDate | 2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.